Table 5 Multivariate logistic regression to determine predictors of selected cardiovascular disease risk factors

 18–34 years

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

  ≥ 35 years

1.7 (0.5–5.2) ^a

0.4 (0.2–0.7)***

1.9 (1.1–3.5)*

–

–

–

 Female

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Male

21.9 (7.7–62.1)***

4.9 (2.7–8.9)***

–

–

0.05 (0.02–0.1)***

0.07 (0.02–0.3)***

 High

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Low

1.9 (0.6–5.8) ^a

–

–

0.5 (0.3–0.9)*

–

–

 Married

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Single

0.7 (0.2–2.5)^a

–

–

1.3 (0.8–2.4) ^a

1.6 (0.7–3.5) ^a

–

 Cohabiting

1.3 (0.4–4.9)^a

–

–

0.3 (0.1–1.1)^a

1.1 (0.4–2.9) ^a

–

 Divorced

4.0 (0.7–21.7)^a

–

–

0.2 (0.03–1.7) ^a

4.1 (1.3–12.7)^*

–

 Separated

0.9 (0.1–6.2) ^a

–

–

0.9 (0.3–3.3) ^a

0.6 (0.2–2.7) ^a

–

 Widowed

0.8 (0.1–5.3) ^a

–

–

1.3 (0.5–3.3) ^a

0.9 (0.4–2.7) ^a

–

 Working

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Not working

–

–

–

–

–

–

 FDC

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 Dumiva and efavirenz

–

0.3 (0.08–0.7)*

1.8 (0.9–3.3)^a

–

2.4 (1.1–5.5)^*

3.4 (1.7–7.0)***

 Dumiva and alluvia

–

0.7 (0.2–1.9)^a

3.2 (1.4–7.4)*

–

0.9 (0.3–3.1)^a

1.2 (0.5–3.1)^a

 Efavirenz and lamividine

–

–

–

–

–

1.7 (0.1–28.4)^a

 Tenamine and neverapine

–

0.4 (0.08–1.8)^a

1.7 (0.6–4.3)^a

–

1.8 (0.5–5.6)^a

1.9 (0.7–5.3)^a

 Alluvia and tenefovir

–

1.5 (0.2–11.0)^a

–

–

1.9 (0.2–20.4)^a

2.8 (0.3–24.5)^a

  ≥ 5 years

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

Reference (1)

 3–4 years

–

–

–

0.7 (0.3–1.6)^a

–

–

  ≤ 2 years

–

–

–

1.7 (0.9–3.1)^a

–

–